home / stock / rdy / rdy news


RDY News and Press, Dr. Reddy's Laboratories Ltd

Stock Information

Company Name: Dr. Reddy's Laboratories Ltd
Stock Symbol: RDY
Market: NYSE
Website: drreddys.com

Menu

RDY RDY Quote RDY Short RDY News RDY Articles RDY Message Board
Get RDY Alerts

News, Short Squeeze, Breakout and More Instantly...

RDY - U.S. Senate passes bill to trim Big Pharma "patent thickets"

2024-07-12 12:35:09 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Teva Pharmaceutical: Buy This Bargain Before It's Gone Teva Pharmaceutical Industries Limited (TEVA) B...

RDY - Long Term Trading Analysis for (RDY)

2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

RDY - Dr. Reddy's to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business

Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...

RDY - Haleon to sell overseas nicotine therapy business to Dr. Reddy's

2024-06-26 08:30:19 ET More on Haleon, Dr. Reddy's, etc. Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Call Transcript Haleon: Pressures Are Temporary, But Closer To Fair Value Sales Call Alvotech and Dr. Reddy’s collaborate for commercializa...

RDY - Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities

Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with pro...

RDY - Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced the appointment of Milan Kalawadia as Chief Executive Officer, North America, and member of the Management Council. As part of...

RDY - Alvotech and Dr. Reddy's Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK

Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK) Alvotech will be responsible for development and manufacture of the product Alvotech (NASDAQ: ALVO), a global biotech compa...

RDY - Alvotech and Dr. Reddy's collaborate for commercialization of denosumab

2024-05-21 08:39:19 ET More on Alvotech, Dr. Reddy's, etc. Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Call Transcript Alvotech: Consider Buying As Positive Q1 Earnings Release Likely Alvotech (ALVO) Q4 2023 Earnings Call Transcript Teva, Alvotech...

RDY - Alvotech and Dr. Reddy's enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK

Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK) Alvotech will be responsible for development and manufacture of the product HYDERABAD, India and REYKJAVIK, Iceland, May ...

RDY - Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Call Transcript

2024-05-07 14:42:05 ET Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Conference Call May 07, 2024 10:00 AM ET Company Participants Richa Periwal - Head of Investor Relations GV Prasad - Co-Chairman and Managing Director Parag Agarwal - Chief Financial O...

Next 10